LH May 2024 240.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.0500

0.0000

(0.00%)

As of 02:21PM EDT. Market open.

Loading interactive chart…

PR Newswire
Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of its first trimester preeclampsia screening test to be performed between 11 and 14 weeks gestation to determine the risk of developing preeclampsia before 34 weeks of pregnancy. It is the only test of its kind available in the United States and is relevant for all pregnant individuals, including those with a low- to average-risk for preeclampsia or first-time pregnancies.
Zacks
Here's Why Investors Should Retain Labcorp (LH) Stock for Now
Investors are optimistic about Labcorp (LH), led by strategic acquisitions and strong expansion in the Biopharma Laboratory.
Simply Wall St.
We Think Shareholders May Want To Consider A Review Of Laboratory Corporation of America Holdings' (NYSE:LH) CEO Compensation Package
Key Insights Laboratory Corporation of America Holdings will host its Annual General Meeting on 14th of May Total pay...